MedTrace Logo

Discovery of Novel Biomarkers of Dietary Exposure in the EPIC Calibration Study

NCT03683654 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 494

Last updated 2018-10-10

No results posted yet for this study

Summary

This proposal aims at identifying new biomarkers of dietary exposure using metabolomic approaches. This project is based on the European Prospective Investigation on Cancer and Nutrition (EPIC) Calibration Study and more particularly upon a subset of 494 men and women from 4 European countries (Germany, Greece, Italy and France). Urine and blood samples are analyzed by untargeted metabolomics.

Conditions

  • Dietary Exposure

Interventions

OTHER

Identify Biomarkers of Dietary Intake in Healthy Subjects

Observational study. No intervention.

Sponsors & Collaborators

  • Imperial College London

    collaborator OTHER

  • Centre for Research in Epidemiology and Population Health (CESP)

    collaborator OTHER

  • Gustave Roussy, Cancer Campus, Grand Paris

    collaborator OTHER

  • German Cancer Research Center

    collaborator OTHER

  • German Institute of Human Nutrition

    collaborator OTHER

  • Hellenic Health Foundation

    collaborator OTHER

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

    collaborator OTHER

  • Cancer Prevention and Research Institute, Italy

    collaborator OTHER

  • Federico II University

    collaborator OTHER

  • Center for Cancer Prevention (CPO)

    collaborator UNKNOWN

  • Azienda Sanitaria Provinciale Ragusa

    collaborator OTHER

  • International Agency for Research on Cancer

    lead OTHER

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-26
Primary Completion
2013-02-23
Completion
2013-02-23

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03683654 on ClinicalTrials.gov